The Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) survey: patients' experience with allergen immunotherapy.

@article{Skoner2014TheAI,
  title={The Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) survey: patients' experience with allergen immunotherapy.},
  author={David Skoner and Michael S. Blaiss and Mark S Dykewicz and Nancy E. Smith and Bryan D Leatherman and Leonard Bielory and Nicole Walstein and Timothy John Craig and Felicia C. Allen-Ramey},
  journal={Allergy and asthma proceedings},
  year={2014},
  volume={35 3},
  pages={219-26}
}
Allergen immunotherapy (AIT) is used for the treatment of allergic rhinoconjunctivitis as a subcutaneous injection (subcutaneous immunotherapy [SCIT]). Extracts used for SCIT are also used off-label to formulate a liquid delivered as sublingual drops (sublingual immunotherapy [SLIT]). This study was designed to survey patients' experiences and beliefs… CONTINUE READING